Evidence map›Paper›PMID 24516549›Full record

ArticlePloS one2014

Non-replicating Mycobacterium tuberculosis elicits a reduced infectivity profile with corresponding modifications to the cell wall and extracellular matrix.

Joanna Bacon, Luke J Alderwick, Jon A Allnutt, Evelina Gabasova, Robert Watson, Kim A Hatch, Simon O Clark, Rose E Jeeves, Alice Marriott, Emma Rayner and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Azetidines Kill Multidrug-ResistantJournal of medicinal chemistry · 2024
    Article
  10. Regulatory role ofFrontiers in microbiology · 2024
    Article
  11. Effect of Mycolic Acids on Host Immunity and Lipid Metabolism.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Antibiotics (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Microbiology spectrum · 2022
    Article
  17. Host- and Age-Dependent Transcriptional Changes inInternational journal of molecular sciences · 2022
    Article
  18. Cell surface (Amsterdam, Netherlands) · 2021
    Article
  19. Article
  20. Investigating β-Lactam Drug Targets inACS infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Joanna BaconPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Luke J AlderwickInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Jon A AllnuttPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Evelina GabasovaMRC Biostatistics Unit, Institute of Public Health, Cambridge, United Kingdom.
Robert WatsonPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Kim A HatchPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Simon O ClarkPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Rose E JeevesPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Alice MarriottPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Emma RaynerPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Howard TolleyPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Geoff PearsonPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Graham HallPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Gurdyal S BesraInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Lorenz WernischMRC Biostatistics Unit, Institute of Public Health, Cambridge, United Kingdom.
Ann WilliamsPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Philip D MarshPublic Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
Public Health England · GBMRC Biostatistics Unit · GBUniversity of Birmingham · GB

Funding

Medical Research Council MC_U105260799
6 · The paper itself

Abstract

A key feature of Mycobacterium tuberculosis is its ability to become dormant in the host. Little is known of the mechanisms by which these bacilli are able to persist in this state. Therefore, the focus of this study was to emulate environmental conditions encountered by M. tuberculosis in the granuloma, and determine the effect of such conditions on the physiology and infectivity of the organism. Non-replicating persistent (NRP) M. tuberculosis was established by the gradual depletion of nutrients in an oxygen-replete and controlled environment. In contrast to rapidly dividing bacilli, NRP bacteria exhibited a distinct phenotype by accumulating an extracellular matrix rich in free mycolate and lipoglycans, with increased arabinosylation. Microarray studies demonstrated a substantial down-regulation of genes involved in energy metabolism in NRP bacteria. Despite this reduction in metabolic activity, cells were still able to infect guinea pigs, but with a delay in the development of disease when compared to exponential phase bacilli. Using these approaches to investigate the interplay between the changing environment of the host and altered physiology of NRP bacteria, this study sheds new light on the conditions that are pertinent to M. tuberculosis dormancy and how this organism could be establishing latent disease.

Indexed as

Adaptation, PhysiologicalAnimalsBacterial LoadCarbohydratesCarbonCell WallChromatography, Thin LayerElectrophoresis, Polyacrylamide GelExtracellular MatrixGene Expression ProfilingGene Expression Regulation, BacterialGuinea PigsMiceMolecular Sequence AnnotationMultigene FamilyMycobacterium InfectionsCarbohydratesCarbonPolysorbates

Identifiers

PMID24516549
PMCPMC3916317
OpenAlexW2069913108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.